The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
miRNA: A Promising Therapeutic Target in Cancer
Open accessAbstract
microRNAs are small non-coding RNAs that regulate several genes post-transcriptionally by complementarity pairing. Since discovery, they have been reported to be involved in a variety of biological functions and pathologies including cancer. In cancer, they can act as a tumor suppressor or oncomiR depending on the cell type. Studies have shown that miRNA-based therapy, either by inhibiting an oncomiR or by inducing a tumor suppressor, is effective in cancer treatment. This review focusses on the role of miRNA in cancer, therapeutic approaches with miRNAs and how they can be effectively delivered into a system. We have also summarized the patents and clinical trials in progress for miRNA therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Xiao, J., Yang, B., Lin, H., Lu, Y., Luo, X., & Wang, Z. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21062 · Cited by 193
RetractedmiR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3
Nassirpour, R., Mehta, P. P., & Yin, M.-J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079655 · Cited by 101
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Origins and Mechanisms of miRNAs and siRNAs
Carthew, R. W., & Sontheimer, E. J. (2009) · Cell · doi:10.1016/j.cell.2009.01.035 · Cited by 5,018
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R., & Ruvkun, G. (2000) · Nature · doi:10.1038/35002607 · Cited by 4,981
MicroRNA genes are transcribed by RNA polymerase II
Lee, Y., Kim, M., Han, J., Yeom, K., Lee, S., Baek, S. H., & Kim, V. N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600385 · Cited by 4,373
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317 · cited 1×
“IL-1-receptor-associated kinase 1 and TNFreceptor-associated factor 6 are the direct targets of miR-146 and are directly involved in inflammatory responses [76].”
BackgroundWolfe, F., Clauw, D. J., Fitzcharles, M., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010) · Arthritis Care & Research · doi:10.1002/acr.20140 · Cited by 3,952 · cited 1×
“Fibromyalgia, which is associated with a lowered pain threshold, has been reported to have dysregulation in miRNA expression [79].”
BackgroundRAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
Yi, R., Qin, Y., Macara, I. G., & Cullen, B. R. (2003) · Genes & Development · doi:10.1101/gad.1158803 · Cited by 3,010
Functional siRNAs and miRNAs exhibit strand bias
Khvorova, A., Reynolds, A., & Jayasena, S. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00801-8 · Cited by 2,645
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
The Drosha-DGCR8 complex in primary microRNA processing
Han, J., Lee, Y., Yeom, K.-H., Kim, Y.-K., Jin, H., & Kim, V. N. (2004) · Genes & Development · doi:10.1101/gad.1262504 · Cited by 2,220
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells
Ebert, M. S., Neilson, J. R., & Sharp, P. A. (2007) · Nature Methods · doi:10.1038/nmeth1079 · Cited by 2,108
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing
Chendrimada, T. P., Gregory, R. I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, K., & Shiekhattar, R. (2005) · Nature · doi:10.1038/nature03868 · Cited by 2,100
Grishok, A., Pasquinelli, A. E., Conte, D., Li, N., Parrish, S., Ha, I., Baillie, D. L., Fire, A., Ruvkun, G., & Mello, C. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00431-7 · Cited by 1,908
CAI, X., HAGEDORN, C. H., & CULLEN, B. R. (2004) · RNA · doi:10.1261/rna.7135204 · Cited by 1,872
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
Requirement of bic/microRNA-155 for Normal Immune Function
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833 · cited 1×
“Studies also show that mice deficient in bic/miRNA-155 are immunodeficient, revealing its importance in regulating T helper cell differentiation and in optimal antibody responses [74,75].”
BackgroundSi, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · cited 1×
“By introducing an extra methylene bridge connecting the 2′-O atom and the 4′-C atom, the ribose moiety of the RNA is “locked” in C3′-endo or C2′-endo conformation, hence the name [137].”
BackgroundHayashita, Y., Osada, H., Tatematsu, Y., Yamada, H., Yanagisawa, K., Tomida, S., Yatabe, Y., Kawahara, K., Sekido, Y., & Takahashi, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2352 · Cited by 1,511
Regulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Lai, E. C. (2002) · Nature Genetics · doi:10.1038/ng865 · Cited by 1,473
MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation
Ørom, U. A., Nielsen, F. C., & Lund, A. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.001 · Cited by 1,384
Decapping and Decay of Messenger RNA Occur in Cytoplasmic Processing Bodies
Sheth, U., & Parker, R. (2003) · Science · doi:10.1126/science.1082320 · Cited by 1,365
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
MicroRNAs Regulate Brain Morphogenesis in Zebrafish
Giraldez, A. J., Cinalli, R. M., Glasner, M. E., Enright, A. J., Thomson, J. M., Baskerville, S., Hammond, S. M., Bartel, D. P., & Schier, A. F. (2005) · Science · doi:10.1126/science.1109020 · Cited by 1,315
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236 · cited 1×
“miRNA-34a has been characterized as a potent tumor suppressor [189].”
BackgroundMicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies
Liu, J., Valencia-Sanchez, M. A., Hannon, G. J., & Parker, R. (2005) · Nature Cell Biology · doi:10.1038/ncb1274 · Cited by 1,234
Regulation of progenitor cell proliferation and granulocyte function by microRNA-223
Johnnidis, J. B., Harris, M. H., Wheeler, R. T., Stehling-Sun, S., Lam, M. H., Kirak, O., Brummelkamp, T. R., Fleming, M. D., & Camargo, F. D. (2008) · Nature · doi:10.1038/nature06607 · Cited by 1,208
miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection
Li, Q.-J., Chau, J., Ebert, P. J. R., Sylvester, G., Min, H., Liu, G., Braich, R., Manoharan, M., Soutschek, J., Skare, P., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.008 · Cited by 1,157
The tumor suppressor microRNA let-7 represses the HMGA2 oncogene
Lee, Y. S., & Dutta, A. (2007) · Genes & Development · doi:10.1101/gad.1540407 · Cited by 1,152
Getting to the Root of miRNA-Mediated Gene Silencing
Eulalio, A., Huntzinger, E., & Izaurralde, E. (2008) · Cell · doi:10.1016/j.cell.2007.12.024 · Cited by 1,079
A microRNA DNA methylation signature for human cancer metastasis
Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803055105 · Cited by 1,078
MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb
Xiao, C., Calado, D. P., Galler, G., Thai, T.-H., Patterson, H. C., Wang, J., Rajewsky, N., Bender, T. P., & Rajewsky, K. (2007) · Cell · doi:10.1016/j.cell.2007.07.021 · Cited by 1,042
Behm-Ansmant, I., Rehwinkel, J., Doerks, T., Stark, A., Bork, P., & Izaurralde, E. (2006) · Genes & Development · doi:10.1101/gad.1424106 · Cited by 1,035
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
Hong, D. S., Kang, Y.-K., Borad, M., Sachdev, J., Ejadi, S., Lim, H. Y., Brenner, A. J., Park, K., Lee, J.-L., Kim, T.-Y., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0802-1 · Cited by 975
Emerging concepts of miRNA therapeutics: from cells to clinic
Diener, C., Keller, A., & Meese, E. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.02.006 · Cited by 971
Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells
Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., Gitt, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4218 · Cited by 939
Beg, M. S., Brenner, A. J., Sachdev, J., Borad, M., Kang, Y.-K., Stoudemire, J., Smith, S., Bader, A. G., Kim, S., & Hong, D. S. (2017) · Investigational New Drugs · doi:10.1007/s10637-016-0407-y · Cited by 897
Transcriptional silencing and promoter methylation triggered by double-stranded RNA
Mette, M. F., Aufsatz, W., van der Winden, J., Matzke, M. A., & Matzke, A. J. M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5194 · Cited by 869
Suppression of non-small cell lung tumor development by the let-7 microRNA family
Kumar, M. S., Erkeland, S. J., Pester, R. E., Chen, C. Y., Ebert, M. S., Sharp, P. A., & Jacks, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712321105 · Cited by 843
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
Svoronos, A. A., Engelman, D. M., & Slack, F. J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0359 · Cited by 791
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Ma, L., Reinhardt, F., Pan, E., Soutschek, J., Bhat, B., Marcusson, E. G., Teruya-Feldstein, J., Bell, G. W., & Weinberg, R. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1618 · Cited by 772
LNA (Locked Nucleic Acid): High-Affinity Targeting of Complementary RNA and DNA
Vester, B., & Wengel, J. (2004) · Biochemistry · doi:10.1021/bi0485732 · Cited by 727
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J., & Fan, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23501 · Cited by 711
van Zandwijk, N., Pavlakis, N., Kao, S. C., Linton, A., Boyer, M. J., Clarke, S., Huynh, Y., Chrzanowska, A., Fulham, M. J., Bailey, D. L., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30621-6 · Cited by 710
MicroRNAs as regulatory elements in immune system logic
Mehta, A., & Baltimore, D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.40 · Cited by 704
miR-221 overexpression contributes to liver tumorigenesis
Pineau, P., Volinia, S., McJunkin, K., Marchio, A., Battiston, C., Terris, B., Mazzaferro, V., Lowe, S. W., Croce, C. M., & Dejean, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907904107 · Cited by 699
The role of PACT in the RNA silencing pathway
Lee, Y., Hur, I., Park, S., Kim, Y., Suh, M. R., & Kim, V. N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600942 · Cited by 696
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., DeSano, J. T., Bommer, G. T., Fan, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006816 · Cited by 689
O'Connell, R. M., Rao, D. S., Chaudhuri, A. A., Boldin, M. P., Taganov, K. D., Nicoll, J., Paquette, R. L., & Baltimore, D. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072108 · Cited by 681
Stem cell division is regulated by the microRNA pathway
Hatfield, S. D., Shcherbata, H. R., Fischer, K. A., Nakahara, K., Carthew, R. W., & Ruohola-Baker, H. (2005) · Nature · doi:10.1038/nature03816 · Cited by 674
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Chen, Y., Gao, D.-Y., & Huang, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.009 · Cited by 672
Trang, P., Wiggins, J. F., Daige, C. L., Cho, C., Omotola, M., Brown, D., Weidhaas, J. B., Bader, A. G., & Slack, F. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.48 · Cited by 667
Cytoplasmic foci are sites of mRNA decay in human cells
Cougot, N., Babajko, S., & Séraphin, B. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200309008 · Cited by 646
The let-7 microRNA reduces tumor growth in mouse models of lung cancer
Esquela-Kerscher, A., Trang, P., Wiggins, J. F., Patrawala, L., Cheng, A., Ford, L., Weidhaas, J. B., Brown, D., Bader, A. G., & Slack, F. J. (2008) · Cell Cycle · doi:10.4161/cc.7.6.5834 · Cited by 593
Sequence-specific inhibition of small RNA function
Hutvágner, G., Simard, M. J., Mello, C. C., & Zamore, P. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020098 · Cited by 584
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Zhang, L., Liao, Y., & Tang, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1059-5 · Cited by 510
The complexity of miRNA-mediated repression
Wilczynska, A., & Bushell, M. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.112 · Cited by 500
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
Garzon, R., Garofalo, M., Martelli, M. P., Briesewitz, R., Wang, L., Fernandez-Cymering, C., Volinia, S., Liu, C.-G., Schnittger, S., Haferlach, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800135105 · Cited by 500
Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer
Toiyama, Y., Takahashi, M., Hur, K., Nagasaka, T., Tanaka, K., Inoue, Y., Kusunoki, M., Boland, C. R., & Goel, A. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt101 · Cited by 499
Structural requirements for pre-microRNA binding and nuclear export by Exportin 5
Zeng, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh824 · Cited by 495
Eteplirsen in the treatment of Duchenne muscular dystrophy
Lim, K. R., Maruyama, R., & Yokota, T. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s97635 · Cited by 495
Transcriptional Control of Gene Expression by MicroRNAs
Khraiwesh, B., Arif, M. A., Seumel, G. I., Ossowski, S., Weigel, D., Reski, R., & Frank, W. (2010) · Cell · doi:10.1016/j.cell.2009.12.023 · Cited by 494
miR-21 plays a pivotal role in gastric cancer pathogenesis and progression
Zhang, Z., Li, Z., Gao, C., Chen, P., Chen, J., Liu, W., Xiao, S., & Lu, H. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.94 · Cited by 477
Posttranscriptional Crossregulation between Drosha and DGCR8
Han, J., Pedersen, J. S., Kwon, S. C., Belair, C. D., Kim, Y.-K., Yeom, K.-H., Yang, W.-Y., Haussler, D., Blelloch, R., & Kim, V. N. (2009) · Cell · doi:10.1016/j.cell.2008.10.053 · Cited by 457
microRNA Therapeutics in Cancer — An Emerging Concept
Shah, M. Y., Ferrajoli, A., Sood, A. K., Lopez-Berestein, G., & Calin, G. A. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.09.017 · Cited by 453
MicroRNA—implications for cancer
Sassen, S., Miska, E. A., & Caldas, C. (2008) · Virchows Archiv · doi:10.1007/s00428-007-0532-2 · Cited by 441
Epigenetic regulation of microRNA expression in colorectal cancer
Bandres, E., Agirre, X., Bitarte, N., Ramirez, N., Zarate, R., Roman‐Gomez, J., Prosper, F., & Garcia‐Foncillas, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24638 · Cited by 439
Micromanagement of the immune system by microRNAs
Lodish, H. F., Zhou, B., Liu, G., & Chen, C.-Z. (2008) · Nature Reviews Immunology · doi:10.1038/nri2252 · Cited by 438
Small‐Molecule Inhibitors of MicroRNA miR‐21 Function
Gumireddy, K., Young, D. D., Xiong, X., Hogenesch, J. B., Huang, Q., & Deiters, A. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200801555 · Cited by 427
C/EBPβ is required for 'emergency' granulopoiesis
Hirai, H., Zhang, P., Dayaram, T., Hetherington, C. J., Mizuno, S.-I., Imanishi, J., Akashi, K., & Tenen, D. G. (2006) · Nature Immunology · doi:10.1038/ni1354 · Cited by 425
A human, ATP-independent, RISC assembly machine fueled by pre-miRNA
Maniataki, E., & Mourelatos, Z. (2005) · Genes & Development · doi:10.1101/gad.1384005 · Cited by 419
Corsten, M. F., Miranda, R., Kasmieh, R., Krichevsky, A. M., Weissleder, R., & Shah, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1045 · Cited by 406
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
Ibrahim, A. F., Weirauch, U., Thomas, M., Grünweller, A., Hartmann, R. K., & Aigner, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4645 · Cited by 400
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
Ji, Q., Hao, X., Meng, Y., Zhang, M., DeSano, J., Fan, D., & Xu, L. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-266 · Cited by 394
Primary microRNA transcripts are processed co-transcriptionally
Morlando, M., Ballarino, M., Gromak, N., Pagano, F., Bozzoni, I., & Proudfoot, N. J. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1475 · Cited by 389
Clustered miRNAs and their role in biological functions and diseases
Kabekkodu, S. P., Shukla, V., Varghese, V. K., D' Souza, J., Chakrabarty, S., & Satyamoorthy, K. (2018) · Biological Reviews · doi:10.1111/brv.12428 · Cited by 358
MicroRNA-9 Regulates Neurogenesis in Mouse Telencephalon by Targeting Multiple Transcription Factors
Shibata, M., Nakao, H., Kiyonari, H., Abe, T., & Aizawa, S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5085-10.2011 · Cited by 342
Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
Yaman Agaoglu, F., Kovancilar, M., Dizdar, Y., Darendeliler, E., Holdenrieder, S., Dalay, N., & Gezer, U. (2011) · Tumor Biology · doi:10.1007/s13277-011-0154-9 · Cited by 341
MicroRNA target site polymorphisms and human disease
Sethupathy, P., & Collins, F. S. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.07.004 · Cited by 333
Shin, K.-J., Wall, E. A., Zavzavadjian, J. R., Santat, L. A., Liu, J., Hwang, J.-I., Rebres, R., Roach, T., Seaman, W., Simon, M. I., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606179103 · Cited by 332
Non-viral vectors for RNA delivery
Yan, Y., Liu, X.-Y., Lu, A., Wang, X.-Y., Jiang, L.-X., & Wang, J.-C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.008 · Cited by 332
Heo, Y.-A. (2020) · Drugs · doi:10.1007/s40265-020-01267-2 · Cited by 317
RNA editing of a miRNA precursor: FIGURE 1.
LUCIANO, D. J., MIRSKY, H., VENDETTI, N. J., & MAAS, S. (2004) · RNA · doi:10.1261/rna.7350304 · Cited by 311
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
Corney, D. C., Hwang, C.-I., Matoso, A., Vogt, M., Flesken-Nikitin, A., Godwin, A. K., Kamat, A. A., Sood, A. K., Ellenson, L. H., Hermeking, H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2642 · Cited by 308
Recent Advances in miRNA Delivery Systems
Dasgupta, I., & Chatterjee, A. (2021) · Methods and Protocols · doi:10.3390/mps4010010 · Cited by 307
Discovering the first microRNA-targeted drug
Lindow, M., & Kauppinen, S. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201208082 · Cited by 302
The Oncogenic Role of miR-155 in Breast Cancer
Mattiske, S., Suetani, R. J., Neilsen, P. M., & Callen, D. F. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0173 · Cited by 302
Sasayama, T., Nishihara, M., Kondoh, T., Hosoda, K., & Kohmura, E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24522 · Cited by 297
A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
Sandoval, J., Mendez-Gonzalez, J., Nadal, E., Chen, G., Carmona, F. J., Sayols, S., Moran, S., Heyn, H., Vizoso, M., Gomez, A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5516 · Cited by 278
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
Reid, G., Pel, M. E., Kirschner, M. B., Cheng, Y. Y., Mugridge, N., Weiss, J., Williams, M., Wright, C., Edelman, J. J. B., Vallely, M. P., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt412 · Cited by 275
Human Glioma Growth Is Controlled by MicroRNA-10b
Gabriely, G., Yi, M., Narayan, R. S., Niers, J. M., Wurdinger, T., Imitola, J., Ligon, K. L., Kesari, S., Esau, C., Stephens, R. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3568 · Cited by 266
PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins
Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P., Rothballer, A., Ascano, M., Jungkamp, A.-C., Munschauer, M., et al. (2010) · Journal of Visualized Experiments · doi:10.3791/2034 · Cited by 259
Melo, S., Villanueva, A., Moutinho, C., Davalos, V., Spizzo, R., Ivan, C., Rossi, S., Setien, F., Casanovas, O., Simo-Riudalbas, L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014720108 · Cited by 253
Sukumar, U. K., Bose, R. J. C., Malhotra, M., Babikir, H. A., Afjei, R., Robinson, E., Zeng, Y., Chang, E., Habte, F., Sinclair, R., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119342 · Cited by 251
Blaszczyk, J., Tropea, J. E., Bubunenko, M., Routzahn, K. M., Waugh, D. S., Court, D. L., & Ji, X. (2001) · Structure · doi:10.1016/s0969-2126(01)00685-2 · Cited by 244
miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancer
Tsuchida, A., Ohno, S., Wu, W., Borjigin, N., Fujita, K., Aoki, T., Ueda, S., Takanashi, M., & Kuroda, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02081.x · Cited by 243
Oncogenic role of miR‐17‐92 cluster in anaplastic thyroid cancer cells
Takakura, S., Mitsutake, N., Nakashima, M., Namba, H., Saenko, V. A., Rogounovitch, T. I., Nakazawa, Y., Hayashi, T., Ohtsuru, A., & Yamashita, S. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00800.x · Cited by 242
Reid, G., Kao, S. C., Pavlakis, N., Brahmbhatt, H., MacDiarmid, J., Clarke, S., Boyer, M., & van Zandwijk, N. (2016) · Epigenomics · doi:10.2217/epi-2016-0035 · Cited by 242
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer
Musumeci, M., Coppola, V, Addario, A., Patrizii, M., Maugeri-Saccà, M., Memeo, L., Colarossi, C., Francescangeli, F., Biffoni, M., Collura, D., et al. (2011) · Oncogene · doi:10.1038/onc.2011.140 · Cited by 236
Rakheja, D., Chen, K. S., Liu, Y., Shukla, A. A., Schmid, V., Chang, T.-C., Khokhar, S., Wickiser, J. E., Karandikar, N. J., Malter, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5802 · Cited by 236
Combination therapy to checkmate Glioblastoma: clinical challenges and advances
Ghosh, D., Nandi, S., & Bhattacharjee, S. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0211-8 · Cited by 227
miRNA biogenesis: Biological impact in the development of cancer
Romero-Cordoba, S. L., Salido-Guadarrama, I., Rodriguez-Dorantes, M., & Hidalgo-Miranda, A. (2014) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.955442 · Cited by 226
DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer
Li, Z., Lei, H., Luo, M., Wang, Y., Dong, L., Ma, Y., Liu, C., Song, W., Wang, F., Zhang, J., et al. (2015) · Gastric Cancer · doi:10.1007/s10120-014-0340-8 · Cited by 225
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
Wu, Y., Crawford, M., Mao, Y., Lee, R. J., Davis, I. C., Elton, T. S., Lee, L. J., & Nana-Sinkam, S. P. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.14 · Cited by 223
Targeting miR-21 for the Therapy of Pancreatic Cancer
Sicard, F., Gayral, M., Lulka, H., Buscail, L., & Cordelier, P. (2013) · Molecular Therapy · doi:10.1038/mt.2013.35 · Cited by 217
Ren, Y., Zhou, X., Mei, M., Yuan, X.-B., Han, L., Wang, G.-X., Jia, Z.-F., Xu, P., Pu, P.-Y., & Kang, C.-S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-27 · Cited by 216
Recombinant Adeno-associated Virus Transduction and Integration
Schultz, B. R., & Chamberlain, J. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.103 · Cited by 215
The Risks of miRNA Therapeutics: In a Drug Target Perspective
Zhang, S., Cheng, Z., Wang, Y., & Han, T. (2021) · Drug Design, Development and Therapy · doi:10.2147/dddt.s288859 · Cited by 211
Hildebrandt, M. A. T., Gu, J., Lin, J., Ye, Y., Tan, W., Tamboli, P., Wood, C. G., & Wu, X. (2010) · Oncogene · doi:10.1038/onc.2010.305 · Cited by 205
Buechner, J., Tømte, E., Haug, B. H., Henriksen, J. R., Løkke, C., Flægstad, T., & Einvik, C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.220 · Cited by 201
Mishra, P. J., Mishra, P. J., Banerjee, D., & Bertino, J. R. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5666 · Cited by 201
Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis
Wang, L.-G., & Gu, J. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2011.05.002 · Cited by 199
Huang, X., Schwind, S., Yu, B., Santhanam, R., Wang, H., Hoellerbauer, P., Mims, A., Klisovic, R., Walker, A. R., Chan, K. K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3191 · Cited by 193
Qian, X., Long, L., Shi, Z., Liu, C., Qiu, M., Sheng, J., Pu, P., Yuan, X., Ren, Y., & Kang, C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.039 · Cited by 186
Role of miR-10b in breast cancer metastasis
Ma, L. (2010) · Breast Cancer Research · doi:10.1186/bcr2720 · Cited by 178
Therapeutic MicroRNA Strategies in Human Cancer
Li, C., Feng, Y., Coukos, G., & Zhang, L. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9145-9 · Cited by 177
XU, Y., AN, Y., WANG, Y., ZHANG, C., ZHANG, H., HUANG, C., JIANG, H., WANG, X., & LI, X. (2013) · Oncology Reports · doi:10.3892/or.2013.2338 · Cited by 169
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155
Neilsen, P. M., Noll, J. E., Mattiske, S., Bracken, C. P., Gregory, P. A., Schulz, R. B., Lim, S. P., Kumar, R., Suetani, R. J., Goodall, G. J., et al. (2013) · Oncogene · doi:10.1038/onc.2012.305 · Cited by 167
Shi, S., Han, L., Deng, L., Zhang, Y., Shen, H., Gong, T., Zhang, Z., & Sun, X. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.005 · Cited by 158
Oncogenic effects of miR-10b in glioblastoma stem cells
Guessous, F., Alvarado-Velez, M., Marcinkiewicz, L., Zhang, Y., Kim, J., Heister, S., Kefas, B., Godlewski, J., Schiff, D., Purow, B., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1047-0 · Cited by 158
miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma.
Yang, C.-C., Hung, P.-S., Wang, P., Liu, C.-J., Chu, T., Cheng, H.-W., & Lin, S.-C. (2011) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2010.01003.x · Cited by 155
Mechanism of miRNA-mediated repression of mRNA translation
Dalmay, T. (2013) · Essays in Biochemistry · doi:10.1042/bse0540029 · Cited by 151
An overview of viral and nonviral delivery systems for microRNA
Yang, N. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.167646 · Cited by 149
Analysis of serum genome-wide microRNAs for breast cancer detection
Wu, Q., Wang, C., Lu, Z., Guo, L., & Ge, Q. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.02.016 · Cited by 148
The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer
Chan, J. K., Blansit, K., Kiet, T. K., Sherman, A. E., Wong, G., Earle, C., & Bourguignon, L. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.01.034 · Cited by 146
Downregulation of miR‐29 contributes to cisplatin resistance of ovarian cancer cells
Yu, P., Yan, M., Lai, H., Huang, R., Chou, Y., Lin, W., Yeh, L., & Lin, Y. (2013) · International Journal of Cancer · doi:10.1002/ijc.28399 · Cited by 138
How nanotechnology can enhance docetaxel therapy
Zhang, L., & Zhang, N. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s46921 · Cited by 137
Clinical pharmacokinetics of second generation antisense oligonucleotides
Yu, R. Z., Grundy, J. S., & Geary, R. S. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.737320 · Cited by 136
Dicer is required for survival of differentiating neural crest cells
Zehir, A., Hua, L. L., Maska, E. L., Morikawa, Y., & Cserjesi, P. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.01.039 · Cited by 135
Baudet, M., Zivraj, K. H., Abreu‐Goodger, C., Muldal, A., Armisen, J., Blenkiron, C., Goldstein, L. D., Miska, E. A., & Holt, C. E. (2011) · Nature Neuroscience · doi:10.1038/nn.2979 · Cited by 135
Identification of Small Molecules That Suppress MicroRNA Function and Reverse Tumorigenesis
Watashi, K., Yeung, M. L., Starost, M. F., Hosmane, R. S., & Jeang, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.062976 · Cited by 127
Aberrant hypermethylation ofmiR-9genes in gastric cancer
Tsai, K., Liao, Y.-L., Wu, C.-W., Hu, L., Li, S., Chan, W., Ho, M., Lai, C.-H., Kao, H.-W., Fang, W., et al. (2011) · Epigenetics · doi:10.4161/epi.6.10.16535 · Cited by 122
miR-221/222: promising biomarkers for breast cancer
Chen, W., Hu, Q., Qiu, M., Zhong, S., Xu, J., Tang, J., & Zhao, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-0750-y · Cited by 119
Peptide-mediated intracellular delivery of miRNA-29b for osteogenic stem cell differentiation
Suh, J. S., Lee, J., Choi, Y., Chong, P. C., & Park, Y. J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.039 · Cited by 119
The fundamental role of miR-10b in metastatic cancer.
Sheedy, P., & Medarova, Z. O. (2018) · Europe PMC (PubMed Central) · Cited by 116
Bellon, A., Iyer, A., Bridi, S., Lee, F. C. Y., Ovando‐Vázquez, C., Corradi, E., Longhi, S., Roccuzzo, M., Strohbuecker, S., Naik, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.093 · Cited by 114
MicroRNAs as therapeutic targets in human cancers
Shah, M., & Calin, G. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1229 · Cited by 113
PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
Liang, G. F., Zhu, Y., Sun, B., Hu, F. H., Tian, T., Li, S., & Xiao, Z. (2011) · Nanoscale Research Letters · doi:10.1186/1556-276x-6-447 · Cited by 112
A comprehensive analysis of precursor microRNA cleavage by human Dicer
Feng, Y., Zhang, X., Graves, P. R., & Zeng, Y. (2012) · RNA · doi:10.1261/rna.033688.112 · Cited by 112
The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment
Uzuner, E., Ulu, G. T., Gürler, S. B., & Baran, Y. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1170-8_18 · Cited by 109
Cai, B., Li, J., Wang, J., Luo, X., Ai, J., Liu, Y., Wang, N., Liang, H., Zhang, M., Chen, N., et al. (2012) · Stem Cells · doi:10.1002/stem.1154 · Cited by 108
Craig, V. J., Tzankov, A., Flori, M., Schmid, C. A., Bader, A. G., & Mueller, A. (2012) · Leukemia · doi:10.1038/leu.2012.110 · Cited by 107
Ye, D., Wang, G., Liu, Y., Huang, W., Wu, M., Zhu, S., Jia, W., Deng, A., Liu, H., & Kang, J. (2012) · Stem Cells · doi:10.1002/stem.1149 · Cited by 107
MiR-17-92 cluster promotes hepatocarcinogenesis
Zhu, H., Han, C., & Wu, T. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv112 · Cited by 104
Wang, X., Li, C., Ju, S., Wang, Y., Wang, H., & Zhong, R. (2011) · Leukemia & Lymphoma · doi:10.3109/10428194.2011.591004 · Cited by 103
Circulating miR-21 as novel biomarker in gastric cancer
Simonian, M., Mosallayi, M., & Mirzaei, H. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.175428 · Cited by 103
Ślusarz, A., & Pulakat, L. (2015) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000246 · Cited by 98
Zhang, L., Yang, X., Lv, Y., Xin, X., Qin, C., Han, X., Yang, L., He, W., & Yin, L. (2017) · Scientific Reports · doi:10.1038/srep46186 · Cited by 93
MicroRNA-directed cleavage of targets: mechanism and experimental approaches
Park, J. H., & Shin, C. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.8.109 · Cited by 89
MicroRNA Conjugated Gold Nanoparticles and Cell Transfection
Crew, E., Rahman, S., Razzak-Jaffar, A., Mott, D. M., Kamundi, M., Yu, G., Tchah, N., Lee, J., Bellavia, M. C., & Zhong, C. (2011) · Analytical Chemistry · doi:10.1021/ac202749p · Cited by 89
Kasar, S. N., Salerno, E., Yuan, Y., Underbayev, C., Vollenweider, D., Laurindo, M. F. L., Fernandes, H., Bonci, D., Addario, A., Mazzella, F. M., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.58 · Cited by 87
MicroRNA-145 Regulates Human Corneal Epithelial Differentiation
Lee, S. K.-W., Teng, Y., Wong, H.-K., Ng, T. K., Huang, L., Peng, L., Choy, K. W., Liu, Y., Zhang, M., Lam, D. S.-C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021249 · Cited by 87
Yigit, M., Ghosh, S. K., Kumar, M., Petkova, V., Kavishwar, A., Moore, A., & Medarova, Z. (2012) · Oncogene · doi:10.1038/onc.2012.173 · Cited by 86
Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors
Herrera-Carrillo, E., Liu, Y. P., & Berkhout, B. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2017.036 · Cited by 86
Gan, Y., Li, H., Wang, J., Gumireddy, K., Li, A., Yao, W., Tang, K., Xiao, W., Hu, J., Xiao, H., et al. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.05.094 · Cited by 85
Pinter, R., & Hindges, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010021 · Cited by 84
Griveau, A., Béjaud, J., Anthiya, S., Avril, S., Autret, D., & Garcion, E. (2013) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2013.05.049 · Cited by 80
Zhou, P., Xu, W., Peng, X., Luo, Z., Xing, Q., Chen, X., Hou, C., Liang, W., Zhou, J., Wu, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068204 · Cited by 77
Exosome based miRNA delivery strategy for disease treatment
Fang, Z., Zhang, X., Huang, H. W., & Wu, J. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.11.050 · Cited by 75
Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles
Kim, J., Yeom, J., Ko, J., Han, M. S., Lee, K., Na, S.-Y., & Bae, J. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.07.014 · Cited by 74
Kim, M. W., Kwon, S., Choi, J. H., & Lee, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123859 · Cited by 70
Let-7: A regulator of the ERα signaling pathway in human breast tumors and breast cancer stem cells
Sun, X., Qin, S., Fan, C., Xu, C., DU, N., & Ren, H. (2013) · Oncology Reports · doi:10.3892/or.2013.2330 · Cited by 67
Role reversal: the regulation of neuronal gene expression by microRNAs
Klein, M. E., Impey, S., & Goodman, R. H. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.08.011 · Cited by 67
Zhou, L., Xu, Z., Xiaoqiang, R., Chen, K., & Xin, S. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443117 · Cited by 67
Shen, J., Wan, R., Hu, G., Yang, L., Xiong, J., Wang, F., Shen, J., He, S., Guo, X., Ni, J., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.02.008 · Cited by 63
Strotbek, M., Schmid, S., Sánchez-González, I., Boerries, M., Busch, H. S., & Olayioye, M. A. (2017) · International Journal of Cancer · doi:10.1002/ijc.30661 · Cited by 63
Iyer, A., Bellon, A., & Baudet, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00078 · Cited by 62
microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression
Tong, S., Liu, J., Wang, X., & Qu, L. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1846 · Cited by 55
Querfeld, C., Pacheco, T. R., Foss, F. M., Halwani, A. S., Porcu, P., Seto, A. G., Ruckman, J., Landry, M. L., Jackson, A. L., Pestano, L. A., et al. (2016) · Blood · doi:10.1182/blood.v128.22.1829.1829 · Cited by 51
Src-Like Adaptor Protein Regulates B Cell Development and Function
Dragone, L. L., Myers, M. D., White, C., Sosinowski, T., & Weiss, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.335 · Cited by 48
Bikram, M., Lee, M., Chang, C., Janat-Amsbury, M.-M., Kern, S. E., & Kim, S. W. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.011 · Cited by 48
Epithelial Cell Differentiation Regulated by MicroRNA-200a in Mammary Glands
Nagaoka, K., Zhang, H., Watanabe, G., & Taya, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065127 · Cited by 48
Zou, Y., Chiu, H., Domenger, D., Chuang, C., & Chang, C. (2012) · Science Signaling · doi:10.1126/scisignal.2002437 · Cited by 47
Inter-patient variability in docetaxel pharmacokinetics: A review
Nieuweboer, A. J. M., de Morrée, E. S., de Graan, A. M., Sparreboom, A., de Wit, R., & Mathijssen, R. H. J. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.04.012 · Cited by 47
Elevated circulating endothelial-specific microRNAs in migraine patients: A pilot study
Cheng, C.-Y., Chen, S., Liao, Y., Fuh, J., Wang, Y.-F., & Wang, S. (2017) · Cephalalgia · doi:10.1177/0333102417742375 · Cited by 47
Transgenic expression of BACH1 transcription factor results in megakaryocytic impairment
Toki, T., Katsuoka, F., Kanezaki, R., Xu, G., Kurotaki, H., Sun, J., Kamio, T., Watanabe, S., Tandai, S., Terui, K., et al. (2004) · Blood · doi:10.1182/blood-2004-07-2826 · Cited by 46
miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs.
Fabbri, E., Brognara, E., Borgatti, M., Lampronti, I., Finotti, A., Bianchi, N., Sforza, S., Tedeschi, T., Manicardi, A., Marchelli, R., et al. (2011) · Epigenomics · doi:10.2217/epi.11.90 · Cited by 41
MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro
Normann, L. S., Aure, M. R. R., Leivonen, S., Haugen, M. H., Hongisto, V., Kristensen, V. N., Mælandsmo, G. M., & Sahlberg, K. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-90385-2 · Cited by 39
Potential of Anti‐Cancer Therapy Based on Anti‐miR‐155 Oligonucleotides in Glioma and Brain Tumours
Poltronieri, P., D’Urso, P. I., Mezzolla, V., & D’Urso, O. F. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12002 · Cited by 38
Schneider, M., Andersen, D. C., Silahtaroglu, A., Lyngbæk, S., Kauppinen, S., Hansen, J. L., & Sheikh, S. P. (2011) · Journal of Molecular Histology · doi:10.1007/s10735-011-9332-8 · Cited by 36
Lee, J., Kim, S., Na, H., & Min, D. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600328 · Cited by 34
Small‐Molecule Inhibitors of MicroRNA miR‐21 Function
Gumireddy, K., Young, D. D., Xiong, X., Hogenesch, J. B., Huang, Q., & Deiters, A. (2008) · Angewandte Chemie · doi:10.1002/ange.200801555 · Cited by 34
Cui, C., Guo, T., Zhang, S., Yang, M.-Y., Cheng, J., Wang, J., Kang, J., Ma, W., Nian, Y., Sun, Z., et al. (2022) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2022.102585 · Cited by 33
Ni, Y., Zhang, K., Liu, X., Yang, T., Wang, B., Fu, L., Lan, A., & Zhou, Y. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.131599 · Cited by 32
Gandham, S. K., Rao, M., Shah, A. P., Trivedi, M. S., & Amiji, M. M. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.03.005 · Cited by 31
Li, L., Gong, Y., Tang, J., Yan, C., Li, L., Peng, W., Cheng, Z., Yu, R., Xiang, Q., Deng, C., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04124-x · Cited by 30
miR-155 drives oncogenesis by promoting and cooperating with mutations in the c-Kit oncogene
Witten, L., Cheng, C. J., & Slack, F. J. (2018) · Oncogene · doi:10.1038/s41388-018-0571-y · Cited by 26
Dehghankelishadi, P., Maritz, M. F., Badiee, P., & Thierry, B. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121585 · Cited by 20
Hei, Y., Wang, S., Xi, X.-X., Wang, H., Guo, Y., Xin, M., Jiang, C., Lu, S., & Zhang, S. (2022) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.12.008 · Cited by 19
MiR103a-3p and miR107 are related to adaptive coping in a cluster of fibromyalgia patients
Braun, A., Evdokimov, D., Frank, J., Sommer, C., & Üçeyler, N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239286 · Cited by 14
Dhuri, K., Pradeep, S. P., Shi, J., Anastasiadou, E., Slack, F. J., Gupta, A., Zhong, X., & Bahal, R. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03383-y · Cited by 12
Cited by
Trials and Tribulations of MicroRNA Therapeutics
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031469 · Cited by 381
miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer
Chakrabortty, A., Patton, D. J., Smith, B. F., & Agarwal, P. (2023) · Genes · doi:10.3390/genes14071375 · Cited by 256
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
Singh, S., Saini, H., Sharma, A., Gupta, S., Huddar, V. G., & Tripathi, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1155254 · Cited by 25
Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy
Hong, J., Sim, D., Lee, B.-H., Sarangthem, V., & Park, R.-W. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02559-5 · Cited by 22
Metadata
- Authors
- Menon, A., Abd-Aziz, N., Khalid, K., Poh, C. L., & Naidu, R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-09-29
- Volume
- 23
- Issue
- 19
- Pages
- 11502
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4297977882
- Cited by
- 357
- References
- 203
- FWCI
- 24.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.